Repligen

Latest news

• Repligen Corporation (RGEN) Stock Price, News, Quote & History (opens in a new tab)

  Yahoo! Finance Canada · Sep 30, 2026

• Form 4 Repligen Corporation For: 28 September (opens in a new tab)

  Investing.com India · Sep 28, 2026

• After a stock-unit release, Repligen (RGEN) withheld 421 shares from its CFO to cover taxes. (opens in a new tab)

  Stock Titan · Sep 28, 2026

• Repligen Rises as Investors Weigh M&A Progress and Fresh Bullish Signals (opens in a new tab)

  Quiver Quantitative · Sep 28, 2026

• Repligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up (opens in a new tab)

  Eastern Progress · Sep 27, 2026

• Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound? (opens in a new tab)

  Eastern Progress · Sep 27, 2026

• Form 4 Repligen Corporation For: 26 September By Investing.com (opens in a new tab)

  Investing.com Canada · Sep 26, 2026

• Repligen CEO Loeillot sells $2.46m in shares By Investing.com (opens in a new tab)

  Investing.com Canada · Sep 26, 2026

• Repligen Stock Price Forecast. Should You Buy RGEN? (opens in a new tab)

  StockInvest.us · Sep 25, 2026

• Repligen (RGEN) CEO sells shares at $190 each after exercising options under a trading plan. (opens in a new tab)

  Stock Titan · Sep 25, 2026

• Repligen Corporation (RGEN) stock price, news, quote and history (opens in a new tab)

  Yahoo Finance Singapore · Sep 25, 2026

• Shares valued at $2.46 million are listed for sale by a Repligen (NASDAQ: RGEN) officer and director. (opens in a new tab)

  Stock Titan · Sep 24, 2026

• (RGEN) Movement as an Input in Quant Signal Sets (opens in a new tab)

  Stock Traders Daily · Sep 23, 2026

• Repligen Corporation stock hits 52-week high at 188.95 USD (opens in a new tab)

  Investing.com · Sep 23, 2026

• Repligen (RGEN) CEO sells 5,426 shares under plan (opens in a new tab)

  Stock Titan · Sep 22, 2026

• Repligen (NASDAQ: RGEN) insider plans new stock sale after two recent trades (opens in a new tab)

  Stock Titan · Sep 21, 2026

• Repligen announces long-serving director Karen Dawes’ retirement (opens in a new tab)

  tipranks.com · Sep 15, 2026

• Repligen Corporation (RGEN) Presents at Wells Fargo 21st Annual Healthcare Conference - Slideshow (opens in a new tab)

  Seeking Alpha · Sep 11, 2026

• UBS Adjusts Price Target on Repligen to $225 From $195, Keeps Buy Rating (opens in a new tab)

  Yahoo Finance · Sep 9, 2026

• 3 Reasons to Avoid RGEN and 1 Stock to Buy Instead (opens in a new tab)

  Yahoo Finance · Sep 9, 2026

• Repligen (RGEN) Stock Looks Near Fair Value After Recent Rebound (opens in a new tab)

  Yahoo Finance · Sep 3, 2026